Literature DB >> 8394459

Translational inhibition mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 (gp48) transcript.

C R Degnin1, M R Schleiss, J Cao, A P Geballe.   

Abstract

The human cytomegalovirus (CMV) virion glycoprotein gpUL4 (gp48) gene expresses a transcript that contains three AUG codons upstream from the one used to initiate synthesis of the gp48 protein. Previously we reported that the second of these AUG codons, AUG2, was necessary but insufficient for inhibition of downstream translation (M. Schleiss, C. R. Degnin, and A. P. Geballe, J. Virol. 65:6782-6789, 1991). We now demonstrate that the coding information of the upstream open reading frame initiated by AUG2 (uORF2) is critical for the inhibitory signal. Several missense mutations, particularly those involving the carboxy-terminal codons of uORF2, inactivate the inhibitory signal, while mutations that preserve the coding content of uORF2 uniformly retain the inhibitory signal. The uORF2 termination codon is essential for inhibition, but leader sequences further downstream are not critical. Conservation of uORF2 among clinical strains of CMV suggests that uORF2 provides an important function in the CMV infectious cycle. Although these results indicate that the peptide product of uORF2 mediates the inhibitory effect, we demonstrate that the uORF2 signal acts only in cis, and we propose a model of inhibition by the gp48 uORF2 signal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394459      PMCID: PMC237954     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Translation of bicistronic viral mRNA in transfected cells: regulation at the level of elongation.

Authors:  J E Fajardo; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Translation initiation at a downstream AUG occurs with increased efficiency when the upstream AUG is located very close to the 5' cap.

Authors:  S A Sedman; G W Gelembiuk; J E Mertz
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit.

Authors:  D A Wright; D H Spector
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Sequences that surround the stop codons of upstream open reading frames in GCN4 mRNA determine their distinct functions in translational control.

Authors:  P F Miller; A G Hinnebusch
Journal:  Genes Dev       Date:  1989-08       Impact factor: 11.361

6.  Model for signal sequence recognition from amino-acid sequence of 54K subunit of signal recognition particle.

Authors:  H D Bernstein; M A Poritz; K Strub; P J Hoben; S Brenner; P Walter
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

7.  Identification and expression of a human cytomegalovirus early glycoprotein.

Authors:  C P Chang; D H Vesole; J Nelson; M B Oldstone; M F Stinski
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

8.  Leader-encoded open reading frames modulate both the absolute and relative rates of synthesis of the virion proteins of simian virus 40.

Authors:  S A Sedman; P J Good; J E Mertz
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication.

Authors:  E S Mocarski; M Bonyhadi; S Salimi; J M McCune; H Kaneshima
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  38 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

Review 2.  Upstream open reading frames as regulators of mRNA translation.

Authors:  D R Morris; A P Geballe
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Abundant early expression of gpUL4 from a human cytomegalovirus mutant lacking a repressive upstream open reading frame.

Authors:  J P Alderete; S J Child; A P Geballe
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.

Authors:  C Deffaud; J L Darlix
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 5.  Control of eukaryotic protein synthesis by upstream open reading frames in the 5'-untranslated region of an mRNA.

Authors:  Hedda A Meijer; Adri A M Thomas
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

6.  Inhibition of translation termination mediated by an interaction of eukaryotic release factor 1 with a nascent peptidyl-tRNA.

Authors:  Deanna M Janzen; Lyudmila Frolova; Adam P Geballe
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

7.  Picky nascent peptides do not talk to foreign ribosomes.

Authors:  Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

Review 8.  Ribosome regulation by the nascent peptide.

Authors:  P S Lovett; E J Rogers
Journal:  Microbiol Rev       Date:  1996-06

9.  Ribosomal release without peptidyl tRNA hydrolysis at translation termination in a eukaryotic system.

Authors:  J Cao; A P Geballe
Journal:  RNA       Date:  1998-02       Impact factor: 4.942

10.  Inhibition of nascent-peptide release at translation termination.

Authors:  J Cao; A P Geballe
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.